tiprankstipranks
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Compare Lepu Biopharma Co. Ltd. Class H (2157) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$10.74B
30.77
58.83%
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
272.41%
2 Buy
1 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$21.06B
-25.84
83.82%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.55B
-77.24
66.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$24.51B
42.36
384.65%
1 Buy
0 Hold
0 Sell
Moderate Buy
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$3.87B
-8.57
-4.24%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.78
1.61
38.61%
HK:1672
Ascletis Pharma, Inc.
17.95
12.18
211.09%
HK:2162
Keymed Biosciences, Inc.
75.00
29.70
65.56%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.24
5.42
42.28%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
60.00
47.72
388.60%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
4.74
-0.66
-12.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts